The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study

References

• Bendstrup E, Møller J, Kronborg-White S, et al. Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians. J Clin Med. 2019;8(12):2038.
   PubMed Web of Science ®Google Scholar
• Fischer A, Distler J. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clin Rheumatol. 2019;38(10):2673–10.
   PubMed Web of Science ®Google Scholar
• Johnson C, Pinal-Fernandez I, Parikh R,… et al. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung. 2016;194(5):733–737.
   PubMed Web of Science ®Google Scholar
• Morales-Cárdenas A, Pérez-Madrid C, Arias L,… et al. Pulmonary involvement in systemic sclerosis. Autoimmun Rev. 2016;15(11):1094–1108.
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM,… et al. An official American thoracic society/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748.
   PubMed Web of Science ®Google Scholar
• Cottin V, Hirani NA, Hotchkin DL,… et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Richeldi L,… et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18–47.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Roth MD, Clements PJ, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4(9):708–719. DOI:10.1016/S2213-2600(16)30152-7.
   PubMed Web of Science ®Google Scholar
• Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–968.
   PubMed Web of Science ®Google Scholar
• Distler O, Highland KB, Gahlemann M,… et al. Nintedanib for systemic sclerosis–associated interstitial lung disease. N Engl J Med. 2019;380(26):2518–2528.
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Wells AU, Cottin V,… et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718–1727.
   PubMed Web of Science ®Google Scholar
• Matteson EL, Kelly C, Distler JH, et al. Nintedanib in patients with autoimmune disease–related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial. Arthritis Rheumatology. 2022;74(6):1039–1047. DOI:10.1002/art.42075.
   PubMed Web of Science ®Google Scholar
• Wells AU, Flaherty KR, Brown KK,… et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8(5):453–460.
   PubMed Web of Science ®Google Scholar
• Cosgrove GP, Bianchi P, Danese S, et al. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18(1):1–9.
   PubMedGoogle Scholar
• Hoyer N, Prior TS, Bendstrup E, et al. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respir Res. 2019;20(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Hilberg O, Muller A, et al. A cohort study of interstitial lung diseases in central Denmark. Respir med. 2014;108(5):793–799.
   PubMed Web of Science ®Google Scholar
• Pritchard D, Adegunsoye A, Lafond E,… et al. Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019;20(1):1–9.
   PubMed Web of Science ®Google Scholar
• Cano-Jiménez E, Vázquez Rodríguez T, Martín-Robles I,… et al. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis. Sci Rep. 2021;11(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hoyer N, Prior TS, Bendstrup E, et al. Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates. BMJ Open Respir Res. 2022;9(1):e001276.
   PubMed Web of Science ®Google Scholar
• Cheema TJ, Young M, Rabold E, et al. Patient and physician perspectives on systemic sclerosis–associated interstitial lung disease. Clin Med Insights: Circ Respir Pulm Med. 2020;14:1179548420913281.
   Web of Science ®Google Scholar
• Hoffmann-Vold AM, Bendstrup E, Dimitroulas T,… et al. Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews. Rheumatology. 2021;60(12):5601–5609.
   PubMed Web of Science ®Google Scholar
• Caminati A, Vigone B, Cozzaglio S,… et al. Expert opinion and patients’ in-depth interviews on the impact of pulmonary complications in systemic sclerosis. Curr Med Res Opin. 2021;37(sup2):17–26.
   PubMedGoogle Scholar
• Lungeforeningen [The Danish Lung Association]. Kunne jeg få lov at være med til barnedåben: En kortlægning af IPF-patienters forløb fra første symptom til diagnose. København: Lungeforeningen; 2019.
   Google Scholar
• Low J. Unstructured and semi-structured interviews in health research. In: Saks M, and Allsop J, editors. Researching Health: qualitative, Quantitative and Mixed Methods. London: Sage; 2013,87–105.
   Google Scholar
• Coffey A, Atkinson P. Making sense of qualitative data: complementary research strategies. California, CA: Sage Publications; 1996.
   Google Scholar
• Guest G, MacQueen KM, Namey EE. Applied thematic analysis. California, CA: Sage Publications; 2012.
   Google Scholar
• Johansen MB, Martin HM. De mange veje til en lungefibrosediagnose. København: VIVE; 2021.
   Google Scholar
• Wijsenbeek M, Deparis N, Valenzuela C, et al. Diagnostic Delays in Interstitial Lung Diseases (ILDs). In: C22. ild: diagnosis. American Thoracic Society; 2019p. A4328.
   Google Scholar
• Alfaro TM, Wijsenbeek MS, Powell P, et al. Educational aspects of rare and orphan lung diseases. Respir Res. 2021;22(1):1–8.
   PubMed Web of Science ®Google Scholar
• Davidsen JR, Lund LC, Laursen CB, et al. Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis. ERJ Open Res. 2020;6(4):00479–2020.
   PubMedGoogle Scholar
• Lamas DJ, Kawut SM, Bagiella E, et al. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med. 2011;184(7):842–847.
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Hilberg O, Pedersen AB, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheumatic Dis. 2017;76(10):1700–1706.
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Bendstrup E, Pedersen AB, et al. Interstitial lung disease in connective tissue diseases: survival patterns in a population-based cohort. J Clin Med. 2021;10(21):4830.
   PubMed Web of Science ®Google Scholar
• Hoffmann-Vold AM, Maher TM, Philpot EE,… et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol. 2020;2(2):e71–83.
   PubMedGoogle Scholar
• Juge PA, Granger B, Debray MP,… et al. POS0062 A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease. Ann Rheumatic Dis. 2022;81(Suppl 1):247–248.
   Google Scholar
• Wang Y, Chen S, Zheng S,… et al. The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases. Arthritis Res Therapy. 2021;23(1):1–10.
   PubMed Web of Science ®Google Scholar